AKR1C3 and prostate neoplasm: We however found high expression levels of certain steroidogenic enzymes; SRD5A1, AKR1C2, AKR1C3, and HSD17B10, in bone metastases when compared to non-malignant prostate and primary prostate tumor tissue.